Delphi advises Mendus in connection with directed share issue

Advokatfirman Delphi has advised Mendus AB (publ) in connection with a directed share issue through a so-called accelerated bookbuilding, whereby Mendus receives gross proceeds of approximately SEK 52.5 million before transaction costs. Mendus’ shares are listed on Nasdaq Stockholm.

Mendus is dedicated to transforming the way cancer is treated by addressing tumor relapse and improving long-term survival for cancer patients, while preserving their health and quality of life.

Delphi’s advisory team consisted of Jenny Lindén, Tove Rodlert and Alexander Bratthall.